Hepatocellular carcinoma (HCC) continues to be a serious medical problem with poor
prognosis worldwide. The distribution of the major etiologies of HCC is changing due to the …

Hepatocellular carcinoma (HCC) is the seventh most highly prevalent malignant tumor
globally and the second most common cause of mortality. HCC develops with complex …

To facilitate the achieving of the goal of" eliminating viral hepatitis as a major public health
threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology …

Antiviral therapy substantially reduces HCC risk in patients... : Hepatology Antiviral therapy
substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate …

BACKGROUND Chronic hepatitis B virus (HBV) infection remains a major global public
health problem. Chronic hepatitis B (CHB) patients can be divided into treatment indication …

Antiviral Therapy Substantially Reduces Hepatocellular Carcinoma Risk in Chronic
Hepatitis B Patients in the Indeterminate Phase Page 1 Antiviral Therapy Substantially …

Chronic hepatitis B (CHB) is the most common cause of hepatocellular carcinoma (HCC)
worldwide. Antiviral treatment reduces the risk of HCC and mortality; nonetheless, globally in …

Background The upper limits of normal (ULNs) of ALT are not consistent across the major
international guidelines which may affect the eligibility for antiviral therapy for chronic …

Chronic hepatitis B virus (HBV) infection is the leading risk factor for hepatocellular
carcinoma (HCC). The aim of this study was to explore the incidence of HCC in a cohort of …

Methods: Using a multinational cohort from Korea, Hong Kong, and Taiwan involving 7,545
HBeAg-positive, non-cirrhotic, adult CHB patients who started entecavir or tenofovir …